Results 151 to 160 of about 80,709 (284)
Myelodysplastic Syndromes: 2026 Update on Diagnosis, Risk‐Stratification and Management
American Journal of Hematology, Volume 101, Issue 9, Page 2393-2411, September 2026.ABSTRACT Disease Overview The myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid disorders characterized by peripheral blood cytopenias and increased risk of transformation to acute myelogenous leukemia (AML). MDS occurs more frequently in older males and in individuals with prior exposure to cytotoxic therapy.
Guillermo Garcia‐Manero
wiley +1 more source
Serum hepcidin and erythropoietin in relation to anemia in non-diabetic chronic kidney disease: a cross-sectional study. [PDF]
Sci RepGamal M +6 more
europepmc +1 more source
Медицина в КузбассеThe aim of the research is to evaluate the expression of erythropoietin in the placentas of women with acute COVID-19 in the third trimester of gestation. Materials and methods. Retrospective study.
Людмила Станиславовна Ищенко +4 more
doaj
Investigating the Role of Type I Interferon Signaling on Muscle Disease Using Mouse Models
Arthritis &Rheumatology, Volume 78, Issue 9, Page 1942-1951, September 2026.Objective Dysregulated type I interferon (IFN) signaling contributes to autoimmune myositis pathogenesis. We investigated the therapeutic effects of JAK inhibitors in two mouse models. We also examined how type I IFNs affect muscle vasculature. Methods Myositis was induced in major histocompatibility complex class I double transgenic ([TRE‐H‐2Kb (H ...
Rita Spathis +11 more
wiley +1 more source
Severe Macrocytic Anemia Associated With a Novel ALAS2 Mutation: A Case Report and Literature Review
Clinical Case Reports, Volume 14, Issue 9, September 2026.ABSTRACT X‐linked sideroblastic anemia (XLSA), caused by pathogenic variants in ALAS2, typically presents as microcytic anemia in males. However, heterozygous females occasionally exhibit an atypical macrocytic phenotype, often leading to diagnostic ambiguity and confusion with nutritional anemias or myelodysplastic syndromes.
Haodong Cai +5 more
wiley +1 more source
Sustained Erythroid Response to Eltrombopag in Low-Risk Myelodysplastic Neoplasms With Severe Anemia and Thrombocytopenia: A Case Report. [PDF]
Case Rep HematolDi Veroli A +7 more
europepmc +1 more source
An overview of erythropoietin therapy
, 2013 Erythropoietin, produced primarily by the kidneys, is the principal factor responsible for the regulation of erythropoiesis. Since its discovery in 1986, human recombinant erythropoietin has revolutionized the management of anemia in chronic kidney ...
van Eps, Carolyn +4 more
core
HemaSphere, Volume 10, Issue 9, September 2026.Abstract Microcytic anemia is among the most common hematological abnormalities in clinical practice and is usually attributable to iron deficiency, thalassemia traits, or anemia of inflammation. A small but clinically important subset of patients, however, has inherited disorders of iron metabolism or heme synthesis presenting with persistent ...
Alexandros Makis +2 more
wiley +1 more source
Ultrapure dialysate reduces dose of recombinant human erythropoietin [PDF]
, 1999 Bergner, A. +2 more
core +1 more source